2
relevant articles (1 outcomes,
0 trials/studies)
found for this Bio-Agent
Description:
chemotherapy protocol consisting of above cpds; used in the treatment of symptomatic advanced non-small-cell lung cancer; PE protocol consists of CISPLATIN & ETOPOSIDE